Akebia Therapeutics (AKBA) Retained Earnings (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Retained Earnings of $6000.0 for Q1 2026, up 100.0% year-over-year from $3000.0 in Q1 2025, and little changed quarter-over-quarter from $6000.0 in Q4 2025.
Akebia Therapeutics (AKBA) Retained Earnings (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Retained Earnings for 14 consecutive years, with $6000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 100.0% year-over-year to $6000.0; the TTM figure through Mar 2026 stood at $6000.0 (up 100.0% YoY), while the FY2025 annual figure was $6000.0, changed 0.0% from the prior year.
- Retained Earnings was little changed at $6000.0 in Q1 2026 per AKBA's latest filing, from $6000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $6000.0 in Q4 2022 and bottomed at -$1.7 billion in Q1 2025.
- Historically, Retained Earnings has averaged -$1.0 billion across 5 years, with a median of -$1.6 billion in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 100.0% — and 2025, when it plunged 27870900.0%.
- Akebia Therapeutics' Retained Earnings stood at $6000.0 in 2022, then tumbled by 26815933.33% to -$1.6 billion in 2023, then soared by 100.0% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025, then changed by 0.0% to $6000.0 in 2026.
- Business Quant data shows AKBA's Retained Earnings at $6000.0 in Q1 2026, $6000.0 in Q4 2025, and -$1.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Akebia Therapeutics | 248.20 Mn | 92.65 Mn | 38.70 Mn | -1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.70 Bn |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -1.67 Bn |
| Jun 30, 2025 | -1.67 Bn |
| Mar 31, 2025 | -1.67 Bn |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -1.66 Bn |
| Jun 30, 2024 | -1.64 Bn |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -1.61 Bn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | -1.60 Bn |
| Mar 31, 2023 | -1.58 Bn |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | -1.55 Bn |
| Jun 30, 2022 | -1.50 Bn |
| Mar 31, 2022 | -1.53 Bn |
| Dec 31, 2021 | -1.46 Bn |
| Sep 30, 2021 | 6,000.00 |